Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 469

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 469
---
al, a director of the Company, is the Chief Investment Officer 
 and Managing Member of Acuta Partners. Dr. Dalal has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and Dr. Dalal disclaim beneficial ownership of the     
 shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein. The principal business address of each of Acuta Capital is c/o Acuta Capital Partners, LLC, 255 Shoreline 
 Drive, Suite 515, Redwood City, California 94065.                                                                                                                                                                                                   |

| (3) | Based solely on a Schedule 13D filed with the SEC on December 31, 2024, the beneficial ownership shown                                                                                                                                                    
 above consists of (i) 60,000 shares that are held by Braden M. Leonard for which Mr. Leonard has sole voting and dispositive power over all such shares; (ii) 3,585,866 shares that are held by BML Investment Partners, L.P. BML Investment              
 Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of 
 the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1)                                          
 of the Exchange Act. The principal business address for the entities and individuals affiliated with 65 E Cedar, Suite 2, Zionsville, IN 46077.                                                                                                           |

| (4) | Consists of (i) 1,959,162 shares to be purchased in the PIPE Offering by EcoR1 Capital Fund Qualified, L.P.                                                                                                                                
 (“Qualified Fund”); (ii) 122,838 shares to be purchased in the PIPE Offering by EcoR1 Capital Fund, L.P. (“Capital Fund”, and together with Qualified Fund, the “EcoR1 Capital Funds”); (iii) 1,736,015 shares that were                   
 previously held by Qualified Fund; and (iv) 109,238 shares that are held by EcoR1 Capital, LLC (“EcoR1”). EcoR1 is the general partner of